NLRP3 and hyperuricemia: Given that TLR4 and the NLRP3 inflammasome play a significant role in hyperuricaemia-related kidney injury, recent scientific efforts have been focusing on the development of drugs that specifically inhibit TLR4 and the NLRP3 inflammasome.